• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Optimization of transdermal and transmucosal drug delivery systems utilizing artificial neural networks

Research Project

Project/Area Number 12672096
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionHoshi University

Principal Investigator

TAKAYAMA Kozo  Hoshi University, Pharmaceutics, Professor, 薬学部, 教授 (00130758)

Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2002: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2001: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2000: ¥1,600,000 (Direct Cost: ¥1,600,000)
KeywordsOptimization / Artificial neural network / Response surface method / Formulation / Transdermal absorption / Chemical enhancer / Drug delivery / Ketoprofen / 薬物送達 / ケトプロフェン / メントール誘導体 / 構造活性相関 / 刺激性
Research Abstract

A pharmaceutical formulation is composed of several formulation factors and process variables. Several responses relating to the effectiveness, usefulness, stability, as well as safety must be optimized simultaneously. Consequently, expertise and experience are required to design acceptable pharmaceutical formulations. A response surface method (RSM) has widely been used for selecting acceptable pharmaceutical formulations. However, prediction of pharmaceutical responses based on the second-order polynomial equation commonly used in RSM, is often limited to low levels, resulting in poor estimations of optimal formulations. A multi-objective simultaneous optimization method incorporating an artificial neural network (ANN) was developed. The method was applied to the optimization of ketoprofen hydrogel formulations including 1-O-ethyl-3-n-butylcyclohexanol as absorption enhancer. ANNs are being increasingly used in pharmaceutical research to predict the nonlinear relationship between causal factors and response variables. The observed results of several characteristics in the optimum formulations coincided well with the predictions, suggesting superior function of the ANN approach.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (91 results)

All Other

All Publications (91 results)

  • [Publications] S.H.Hwang: "High entrapment of insulin and bovine serum albumin into neutral and positively-charged liposomes by the remote loading method"Chem.Pharm.Bull.. 48. 325-329 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Onuki: "In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption"Int.J.Pharm.. 198. 147-156 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Obata: "Effect of synthesized cyclohexanol derivatives using L-menthol as a lead compound on the percutaneous absorption of ketoprofen"Int.J.Pharm.. 198. 191-200 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Maitani: "The enhancing effect of soybean-derived sterylglucoside and β-sitosterol β-D-glucoside on nasal absorption in rabbits"Int.J.Pharm.. 2000. 17-26 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 浅井和範: "薬物血中濃度分析における固相抽出法を用いたセミミクロ高速液体クロマトグラフィーの有用性"病院薬学. 26. 219-226 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Obata: "Evaluation of skin damage caused by percutaneous absorption enhancers using fractal analysis"J.Pharm.Sci.. 89. 556-561 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 小幡誉子: "ジルチアゼムの皮膚透過に及ぼすメントールおよびO-エチルメントールの効果"DDS. 15. 129-136 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Muramatsu: "Electron spin resonance studies of dipalmitoylphosphatidylcholine liposomes containing soybean-derived sterylglucoside"Chem.Pharm.Bull.. 48. 610-613 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Takayama: "Formula optimization of theophylline tablet based on artificial neural networks"J.Controlled Rel.. 68. 145-186 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J.P.Wang: "In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome"Int. J. Pharm.. 203. 61-69 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Kajita: "Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid"J.Pharm.Sci.. 89. 1243-1252 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Maitani: "Physicochemical characteristics and transfection efficiency of DNA in liposomes with soybean-derived sterylglucoside into HepG2 cells"J.Pharm.Sci.Technol., Jpn.. 61. 1-10 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Morishita: "Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin"Int.J.Pharm.. 212. 289-293 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 岩田政則: "徐放性プロカイン坐薬の物性と薬物吸収に対するカプリン酸ナトリウムの添加効果"医療薬学. 27. 137-142 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Obata: "Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen"Int.J.Pharm.. 212. 223-231 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J.P.Wang: "Pharmacokinetics and antitumor effect of doxorubicin carried by stealth and remote loading proliposome"Pharm.Res.. 17. 782-787 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 宮崎靖則: "反対荷電を持つデキストラン誘導体間の複合体形成に関する検討"薬剤学. 61. 59-70 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Maitani: "Modified ethanol injection method for liposomes containing β-sitosterol β-D-glucoside"J.Liposome Research. 11. 115-125 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Maitani: "Efficency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells"J.Controlled Rel.. 75. 137-142 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] C.J.Li: "Promoting mechanism of menthol derivatives, 1-O-ethyl-3-buthylcylohexanol, on the percutaneous absorption of ketoprofen"Biol.Pharm.Bull.. 24. 1044-1048 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] P.C.Wu: "Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer"J.Pharm.Sci.. 90. 1004-1014 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] S.H.Hwang: "Liver-targeted gene transfer into a human hepattoblastoma cell line and in vivo by steryglucoside-containg cationic liposomes"Gene Therapy. 8. 1276-1280 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] T.Watanabe: "Utility of the three-dimensional cultured human skin model as a tool to evaluate skin permeation of drugs"Altern.Animal Test.Experiment.. 8. 1-14 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 安野伸浩: "Ethenzamideの経皮吸収に及ぼすN-Methyl-2-pyrrolidoneの効果"薬剤学. 61. 154-162 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Nakamura: "Enhancement of FITC-dextran absorption via nasal mucosa by nanoparticles based on β-sitosterol β-D-glucoside and its aglycon"S.T.P.Pharm., Sci.. 12. 63-68 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 宮崎靖則: "固体状態におけるデキストラン誘導体の粘膜付着性の評価"薬剤学. 62. 14-22 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Nakamura: "The enhancing effect of nasal absorption of FITC-dextran 4,400 by β-sitosterol β-D-glicoside in rabbits"J.Controlled Rel.. 79. 147-155 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J.P.Wang: "Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol and PEG-lipid"J.Pharm.Sci.. 91. 1128-1134 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Kawano: "Liver targeting liposomes containing β-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells"Biol.Pharm.Bull.. 25. 766-770 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Kanebako: "Transdermal delivery of indomethacin by iontophoresis"Biol.Pharm.Bull.. 25. 779-782 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J.Sudo: "Elevation of plasma levels of L-dopa in transdermal administration of L-dopa-butylester in rats"Drug Dev.Ind.Pharm.. 28. 59-65 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Morishita: "Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers"J.Controlled Rel.. 81. 25-32 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Tsutsumi: "Buccal absorption of ergotamine tertrate using the bioadhesive tablet system in guinea-pigs"Int.J.Pharm.. 238. 161-170 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y.Morita: "Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera"Chem.Pharm.Bull.. 50. 1181-1186 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Asai: "The effects of water-soluble cyclodextrine on the histological integrity of the rat nasal mucosa"Int.J.Pharm.. 246. 25-35 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Kanebako: "Evaluation of skin barrier function using direct current I : Effect of conductivity, voltage, distance between electrodes and electrode area"Biol.Pharm.Bull.. 25. 1456-1460 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 小川法子: "花粉症治療を目的としたflunisolide含有持続性鼻腔用軟膏の開発"薬剤学. 63. 161-168 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Kanebako: "Evaluation of skin barrier function using direct current II : Effects of duty cycle, waveform, frequency and mode"Biol.Pharm.Bull.. 25. 1623-1628 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Nakamura: "Regional intestinal absorption of FITC-dextran 4,400 with nanoparticles based on β-sitosterol β-D-glucoside in rats"J.Pharm.Sci.. 92. 311-318 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Takayama: "A novel method based on artificial neural networks for optimizing transdermal drug delivery systems, Handbook of Pharmaceutical Controlled Release Technology"Marcel Dekker, Inc.. 890 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] S. H. Hwang, Y. Maitani, K. Takayama and T. Nagai: "High entrapment of insulin and bovine serum albumin into neutral and positively-charged liposomes by the remote loading method"Chem. Pharm. Bull.. 48. 325-329 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Onuki, M. Morishita, K. Takayama, S. Tokiwa, Y. Chiba, K. Isowa and T. Nagai: "In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption"Int. J. Pharm.. 198. 147-156 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Obata, H. Sato, C. J. Li, K. Takayama, K. Higashiyama, T. Nagai and K. Isowa: "Effect of synthesized cyclohexanol derivatives using L-menthol as a lead compound on the percutaneous absorption of ketoprofen"Int. J. Pharm.. 198. 191-200 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Maitani, K. Nakamura, H. Suenaga, K. Kamata, K. Takayama and T. Nagai: "The enhancing effect of soybean-derived sterylglucoside and β-sitosterol β-D-glucoside on nasal absorption in rabbits"Int. J. Pharm.. 200. 17-26 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Obata, T. Sesumi, K. Takayama, K. Isowa, S. Grosh, S. Wick, R. Sitz and T. Naga: "Evaluation of skin damage caused by percutaneous absorption enhancers using fractal analysis"J. Pharm. Sci.. 89. 556-561 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Muramatsu, T. Masumizu, Y. Maitani, S. H. Hwang, M. Kohno, K. Takayama and T. Nagai: "Electron spin resonance studies of dipalmitoylphosphatidylcholine liposomes containing soybean-derived sterylglucoside"Chem. Pharm. Bull.. 48. 610-613 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Takayama, A. Morva, M. Fujikawa, Y. Hattori, Y. Obata and T. Nagai: "Formula optimization of theophylline tablet based on artificial neural networks"J. Controlled Rel.. 68. 145-186 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J. P. Wang, Y. Maitani, K. Takayama and T. Nagai: "In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome"Int. J. Pharm.. 203. 61-69 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M. Kajita, M. Morishita, K. Takayama, Y. Chiba, S. Tokiwa and T. Nagai: "Enhanced enteral bioavailability of vancomycin uisng water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid"J. Pharm. Sci.. 89. 1243-1252 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Maitani, S. H. Hwang, S. Tanaka, K. Takayama and T. Nagai: "Physicochemical characteristics and transfection efficiency of DNA in liposomes with soybean-derived sterylglucoside into HepG2 cells"J. Pharm. Sci. Technol, Jpn.. 61. 1-10 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M. Morishita, J. M. Barichello, K. Takayama, Y. Chiba, S. Tokiwa and T. Nagai: "Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin"Int. J. Pharm.. 212. 289-293 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Obata, C. J. Li, M. Fujikawa, K. Takayama, H. Sato, K. Higashiyama, K. Isowa and T. Nagai: "Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network"Int. J. Pharm.. 212. 223-231 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J. P. Wang, Y. Maitani, K. Takayama and T. Nagai: "Pharmacokinetics and antitumor effect of doxorubicin carried by stealth and remote loading proliposome"Pharm. Res.. 17. 782-787 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Maitani, H. Soeda, J. P. Wang and K. Takayama: "Modified ethanol injection method for liposomes containing -sitosterol -D-glucoside"J. Liposome Research. 11. 115-125 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Maitani, K. Kawano, K. Yamada, T. Nagai and K. Takayama: "Efficency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells"J. Controlled Rel.. 75. 137-142 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] C. J. Li, K. Higashiyama, Y. Yoshimura, T. Nagai, K. Takayama and Y. Obata: "Promoting mechanism of menthol derivatives, 1-O-ethyl-3-buthylcylohexanol, on the percutaneous absorption of ketoprofen"Biol. Pharm. Bull.. 24. 1044-1048 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] P. C. Wu, Y. Obata, M. Fujikawa, C. J. Li, K. Higashiyama and K. Takayama: "Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer"J. Pharm. Sci.. 90. 1004-1014 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] S. H. Hwang, K. Hayashi, K. Takayama and Y. Maitani: "Liver-targeted gene transfer into a human hepattoblastoma cell line and in vivo by sterylglucoside-containg cationic liposomes"Gene Therapy. 8. 1276-1280 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] T. Watanabe, T. Hasegawa, H. Takahashi, T. Ishibashi, K. Takayama and K.Sugibayashi: "Utility of the three-dimensional cultured human skin model as a tool to evaluate skin permeation of drugs"Altern. Animal Test. Experiment.. 8. 1-14 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Nakamura, Y. Maitani and K. Takayama: "Enhancement of FITC-dextran absorption via nasal mucosa by nanoparticles based on β-sitosterol β-D-glucoside and its aglycon"S.T.P. Pharm., Sci.. 12. 63-68 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Nakamura, Y. Maitani and K. Takayama: "The enhancing effect of nasal absorption of FITC-dextran 4,400 by β-sitosterol β-D-glicoside in rabbits"J. Controlled Rel.. 79. 147-155 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J. P. Wang, Y. Maitani and K. Takayama: "Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol and PEG-lipid"J. Pharm. Sci.. 91. 1128-1134 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Kawano, K. Nakamura, K. Hayashi, T. Nagai, K. Takayama and Y. Maitani: "Liver targeting liposomes containing β-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells"Biol. Pharm. Bull.. 25. 766-770 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M. Kanebako, T. Inagi and K. Takayama: "Transdermal delivery of indomethacin by iontophoresis"Biol. Pharm. Bull.. 25. 779-782 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] J. Sudo, U. Iwase, K. Higashiyama, K. Kakuno, F. Miyasaka, T. Meguro and K. Takayama: "Elevation of plasma levels of L-dopa in transdermal administration of L-dopa-butylester in rats"Drug Dev. Ind. Pharm.. 28. 59-65 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M. Morishita, A. M. Lowman, K. Takayama, T. Nagai and N. A. Peppas: "Elucidation of the mechanism of incorporation of insulin in controlled irelease systems based on complexation polymers"J. Controlled Rel.. 81. 25-32 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Tsutsumi, Y. Obata, T. Nagai, T. Loftsson and K. Takayama: "Buccal absorption of ergotamine tertrate using the bioadhesive tablet system in guinea-pigs"Int. J. Pharm.. 238. 161-170 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Y. Morita, Y. Tsushima, M. Yasui, R. Termoz, J. Ajioka and K. Takayama: "Evaluation of the disintegration time of rapidly disintegrating tablets via a movel method utilizing a CCD camera"Chem. Pharm. Bull.. 50. 1181-1186 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Asai, M. Morishita, H. Katsuta, S. Hosoda, K. Shinomiya, M. Noro, T. Nagai and K. Takayama: "The effects of water-soluble cyclodextrine on the histolegical integrity of the rat nasal mucosa"Int. J. Pharm.. 246. 25-35 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M. Kanebako, T. Inagi and K. Takayama: "Evaluation of skin barrier function using direct current I: Effect of conductivity, voltage, distance between electrodes and electrode area"Biol Pharm. Bull.. 25. 1456-1460 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M. Kanebako, T. Inagi and K. Takayama: "Evaluation of skin barrier function using direct current II: Effects of duty cycle, waveform, frequency and mode"Biol Pharm. Bull.. 25. 1623-1628 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K. Nakamura, K. Takayama, T, Nagai and Y. Maitani: "Regional intestinal absorption of FITC-dextran 4,400 with nanoparticles based on β-sitosterol β-D-glucoside in rats"J. Pharm, Sci.. 92. 311-318 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Nakamura: "Regional intestinal absorption of FITC-dextran 4,400 with nanoparticles based on β-sitosterol β-D-glucoside in rats"J. Pharm. Sci.. 92. 311-318 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Kanebako: "Evaluation of skin barrier function using direct current II : Effects of duty cycle, waveform, frequency and mode"Biol. Pharm. Bull.. 25. 1623-1628 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小川法子: "花粉症治療を目的としたflunisolide含有持続性鼻腔用軟膏の開発"薬剤学. 63. 161-168 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Kanebako: "Evaluation of skin barrier function using direct current I : Effects of conductivity, voltage, distance between electrodes and electrode area"Biol. Pharm. Bull.. 25. 1456-1460 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] K.Asai: "The effects of water-soluble cyclodextrine on the histological integrity of the rat nasal mucosa"Int. J. Pharm.. 246. 25-35 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Y.Morita: "Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera"Chem. Pharm. Bull.. 50. 1181-1186 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] K.Nakamura: "Enhancement of FITC-dextran absorption via nasal mucosa by nanoparticles based on β-sitosterol β-D-glucoside and its aglycon"S.T.P. Pharma., Sci.. 12. 63-68 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] P.C.Wu: "Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous"J. Pharm. Sci.. 90. 1004-1014 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] C.J.Li: "Promoting mechanism of menthol derivatives, 1-O-ethyl-3-buthylcylohexanol, on the percutaneous absorption of ketoprofen"Biol. Pharm. Bull.. 24. 1044-1048 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Y.Maitani: "Efficency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells"J. Controlled Rel.. 75. 137-142 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] J.P.Wang: "Pharmacokinetics and antitumor effect of doxorubicin carried by steaklth and remote loading proliposome"Pharm. Res.. 17. 782-787 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Y.Obata: "Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural"Int. J. Pharm.. 212. 223-231 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] K.Takayama: "Handbook of Pharmaceutical Controlled Release Technology"Marcel Dekker, Inc.. 890 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] P.C.Wu: "Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethylbutylcyclohexanol"J.Pharm.Sci.. (印刷中).

    • Related Report
      2000 Annual Research Report
  • [Publications] Y.Obata: "Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen"Int.J.Pharm.. (印刷中).

    • Related Report
      2000 Annual Research Report
  • [Publications] M.Kajita: "Enhanced enteral bioavailability of vancomycin uisng water-in-oil-in-water multiple emulsion incorporating unsaturated fatty acid"J.Pharm.Sci.. 89. 1243-1252 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] W.Junping: "In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome"Int.J.Pharm.. 203. 61-69 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] K.Takayama: "Formula optimization of theophylline tablet based on artificial neural networks"J.Controlled Rel.. 68. 175-186 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] K.Muramatsu: "Electron spin resonance studies of dipalmitoylphosphatidylcholine liposomes containing soybean-derived sterylglucoside"Chem.Pharm.Bull.. 48. 610-613 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi